Association of serum galectin-3 levels with mortality and cardiovascular disease outcomes in hemodialysis patients: a systematic review and dose-response meta-analysis.
Ioannis BellosSmaragdi MarinakiPagona LagiouVassiliki BenetouPublished in: International urology and nephrology (2024)
This study suggests that high serum galectin-3 levels are associated with greater all-cause mortality risk among patients on maintenance hemodialysis. Preliminary cross-sectional evidence indicates that serum galectin-3 may be associated with arterial stiffness and left ventricular dysfunction.
Keyphrases
- cardiovascular disease
- systematic review
- left ventricular
- cross sectional
- heart failure
- blood pressure
- chronic kidney disease
- oxidative stress
- risk factors
- acute myocardial infarction
- adipose tissue
- randomized controlled trial
- end stage renal disease
- aortic stenosis
- transcatheter aortic valve replacement
- left atrial
- insulin resistance
- ejection fraction
- glycemic control